You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Invitae expects that Genosity's software and data management platform will allow it to quickly advance several oncology tests in development.
The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen, also announced plans for an IPO early next year.
BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Sanford Health will help validate TruGenomix's TruGen-1 post-traumatic stress disorder test through its Imagenetics clinical genomics program.
Under the agreement, NeoGenomics will also make a $25 million equity investment in Inivata with an option to buy the company outright.
The funds will be used to support the molecular diagnostics company's growth strategy and for general corporate purposes, MDxHealth said.
The deals are with institutional investors and more than 1 million American Depositary Shares will be offered at A$1.75 per ADS.
The new Series B investment was made by Northpond Ventures, with previously invested $20 million in the Australian diagnostics company.
Uppsala University spinout Astrego has developed a system to rapidly detect bacterial infection and antibiotic susceptibility in biofluid.